Stocks
G1 Therapeutics (GTHX) ROE US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| ROE, % | ? | 36.2% | 22.8% | 25.4% | -214.6% | -135.6% | -110.3% | |
| Changes by years, y/y, % | -4pp | -13pp | +3pp | -240pp | +79pp | |||
G1 Therapeutics. ROE, %
G1 Therapeutics. ROE, changes, pp
G1 Therapeutics (GTHX) ROE US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROE, % | ? | 17.6% | -143.8% | 9.84% | -149.5% | -110.3% | -110.3% | |
| Changes by years, y/y, % | +191pp | +122pp | +355pp | +72pp | -128pp | |||
| Changes by quarters, q/q, % | +239pp | -161pp | +154pp | -159pp | +39pp | |||
